Gevorg Tamamyan: Happy Birthday OncoDaily

FDA Grants Approval for Oral Decitabine/Cedazuridine with Venetoclax in Newly Diagnosed AML

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

Grand Rounds by OncoDaily: AI in Oncology Edition

Herbert Loong Invites to Attend the Sarcoma Grand Rounds at ASCO 2026

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

IMDC Risk Score Calculator (Metastatic RCC)

Classify metastatic Renal Cell Carcinoma (RCC) prognosis using IMDC (International Metastatic RCC Database Consortium) criteria.

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

IMDC Risk Factors:

  • Time from diagnosis to treatment <1 year
  • Karnofsky Performance Status <80
  • Hemoglobin below LLN
  • Corrected calcium above ULN
  • Neutrophils above ULN
  • Platelets above ULN

Risk Categories:

  • Favorable: 0 risk factors
  • Intermediate: 1-2 risk factors
  • Poor: ≥3 risk factors

LLN = Lower Limit of Normal, ULN = Upper Limit of Normal